Steven Tenn is speaking on this topic. He will discuss the economic and econometric tools used to evaluate the competitive impact of hospital mergers.
For more inforamation on this event, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
